45 results
Page 2 of 3
8-K
EX-99.1
wm59f dple
23 Mar 20
DiaMedica Therapeutics Announces 2019 Financial Results and Provides Business Update
4:31pm
424B5
q85lzlx4b uhys80s
11 Feb 20
Prospectus supplement for primary offering
5:31pm
8-K
EX-99.2
xyql2 3qfmbm64hu
11 Feb 20
Updated Financial Information
7:05am
424B5
15o9mv
11 Feb 20
Prospectus supplement for primary offering
7:02am
DEF 14A
or4e53 plgc
8 Apr 19
Definitive proxy
6:04am
PRE 14A
p1p6ay7h
20 Mar 19
Preliminary proxy
4:31pm
10-K
r7ut59cy0
19 Mar 19
Annual report
4:58pm
10-K
EX-10.9
hsrqn 9o38
19 Mar 19
Annual report
4:58pm
10-K
EX-10.7
cvnfate13 wmrayg
19 Mar 19
Annual report
4:58pm
424B4
4uq 05hfyycx1c3
10 Dec 18
Prospectus supplement with pricing info
4:50pm
S-1/A
o0q9p8t59jw0jg7u56w
19 Nov 18
IPO registration (amended)
5:01pm
S-1
EX-10.7
oj1yrqqd0llz51idw0t
9 Nov 18
IPO registration
4:21pm
S-1
n2v7y6umobpk51cp91gg
9 Nov 18
IPO registration
4:21pm
S-1
EX-10.14
2gl2 3prwox3un
9 Nov 18
IPO registration
4:21pm
S-1
EX-10.6
tg63xugz v2s4s08kjs
9 Nov 18
IPO registration
4:21pm
DRS
EX-10.6
xho46bwmr8s 4rdfm15p
1 Nov 18
Draft registration statement
12:00am
DRS
qqiu5dy qi8vh695n1m
1 Nov 18
Draft registration statement
12:00am
DRS
EX-10.7
cico0vskf
1 Nov 18
Draft registration statement
12:00am